✦ LIBER ✦

Deactivation of vascular endothelium by monoclonal anti–tumor necrosis factor α antibody in rheumatoid arthritis

✍ Scribed by Ewa M. Paleolog; Mary Hunt; Michael J. Elliott; Marc Feldmann; Ravinder N. Maini; James N. Woody

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 958 KB
Volume: 39
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780390703

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of rheumatoid arthritis with c

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

✍ Michael J. Elliott; Ravinder N. Maini; Marc Feldmann; Alice Long-Fox; Peter Char 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1018 KB

Reduction of NOS2 overexpression in rheu

Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor α monoclonal antibody (cA2)

✍ Douglas J. Perkins; E. William St. Clair; Mary A. Misukonis; J. Brice Weinberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

Decrease in cellularity and expression o

Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis

✍ Paul P. Tak; Peter C. Taylor; Ferdinand C. Breedveld; Tom J. M. Smeets; Mohamed 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB

Decrease in cell adhesion molecules by t

Decrease in cell adhesion molecules by treatment with anti-tumor necrosis factor α monoclonal antibody

✍ Malcolm D. Smith 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Modulation of angiogenic vascular endoth

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis

✍ Ewa M. Paleolog; Sylvia Young; Alison C. Stark; Richard V. McCloskey; Marc Feldm 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 804 KB

## Objective: To investigate the regulation of expression of the angiogenic cytokine vascular endothelial growth factor (vegf) in rheumatoid arthritis (ra), in order to determine whether new blood vessel formation could be a potential therapeutic target in ra. ## Methods: Dissociated ra synovial

Modulation of CD28 expression with anti–

Modulation of CD28 expression with anti–tumor necrosis factor α therapy in rheumatoid arthritis

✍ Ewa Bryl; Abbe N. Vallejo; Eric L. Matteson; Jacek M. Witkowski; Cornelia M. Wey 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 1 views